0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Research Grade Antibodies Market Research Report 2025
Published Date: November 2025
|
Report Code: QYRE-Auto-9Y12712
Home | Market Reports | Science| Biological Sciences
Global Research Grade Antibodies Market Research Report 2022
BUY CHAPTERS

Global Research Grade Antibodies Market Research Report 2025

Code: QYRE-Auto-9Y12712
Report
November 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Research Grade Antibodies Market Size

The global market for Research Grade Antibodies was valued at US$ 4535 million in the year 2024 and is projected to reach a revised size of US$ 7895 million by 2031, growing at a CAGR of 7.8% during the forecast period.

Research Grade Antibodies Market

Research Grade Antibodies Market

An antibody (also known as an immunoglobulin) is a protective protein produced by the immune system in response to the presence of an antigen. It is a Y-shaped molecule composed of two heavy chains and two light chains, which are held together by disulfide bonds. Each tip of its Y-shaped structure contains a paratope that can specifically bind with an epitope on a corresponding antigen. The antibodies can be then used in a multitude of applications, including but not limited to: western blot (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry (IHC), chromatin immunoprecipitation (ChIP), and flow cytometry (FC). As a cornerstone of the body’s immune response, antibodies can provide significant data to support scientists’ research.
The growth of the research antibodies market is primarily driven by increasing investment in life sciences, rapid expansion of the biopharmaceutical industry, and the adoption of advanced research technologies. Globally, governments, academic institutions, and private organizations are allocating greater funding to fundamental biological and medical research, particularly in areas such as immunology, molecular biology, cancer biology, and infectious diseases, which directly fuels antibody demand. Pharmaceutical and biotech companies rely heavily on antibodies for target identification, drug screening, and biomarker validation, leading to a steady rise in commercial antibody consumption. Emerging fields such as precision medicine, single-cell analysis, and spatial omics have also created new demand for high-quality, validated antibodies. Furthermore, the proliferation of universities, CROs (Contract Research Organizations), and core research facilities has expanded the user base of research antibodies. At the same time, the growing standardization of antibody production, the shift toward recombinant and renewable antibody formats, and the convenience of e-commerce distribution platforms have improved product accessibility and reliability. Overall, the research antibodies market is driven by increased R&D spending, innovation in biomedical research, diversification of application areas, and continuous improvements in antibody quality and availability.
This report aims to provide a comprehensive presentation of the global market for Research Grade Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Research Grade Antibodies.
The Research Grade Antibodies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Research Grade Antibodies market comprehensively. Regional market sizes, concerning products by Source, by End User, by Host Species and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Research Grade Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Source, by End User, and by regions.
Market Segmentation

Scope of Research Grade Antibodies Market Report

Report Metric Details
Report Name Research Grade Antibodies Market
Accounted market size in year US$ 4535 million
Forecasted market size in 2031 US$ 7895 million
CAGR 7.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Source
  • Monoclonal Antibodies
  • Polyclonal Antibodies
Segment by Host Species
  • Mouse Antibody
  • Rabbit Antibody
  • Goat Antibody
  • Sheep Antibody
  • Donkey Antibody
  • Chicken Antibody
  • Others
Segment by Application
  • For Basic Research
  • For Drug Discovery
  • For Translational/Diagnostic Research
  • Others
Segment by End User
  • Pharmaceutical & Biotechnology Companies
  • CRO/CDMO Companies
  • Academic & Research Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abcam, Merck, CST, Thermo Fisher, R&D Systems, BD, Biolegend, Proteintech, ABclonal, Bio-Rad, Santa Cruz Biotechnology (SCBT), Novus Biologicals, Genetex, Abnova, Abcepta, Aviva Biosciences, MBL, BioXCell, Sino Biological, HuaBio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Source, by End User, by Host Species etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Research Grade Antibodies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Source, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by End User, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Research Grade Antibodies Market growing?

Ans: The Research Grade Antibodies Market witnessing a CAGR of 7.8% during the forecast period 2025-2031.

What is the Research Grade Antibodies Market size in 2031?

Ans: The Research Grade Antibodies Market size in 2031 will be US$ 7895 million.

Who are the main players in the Research Grade Antibodies Market report?

Ans: The main players in the Research Grade Antibodies Market are Abcam, Merck, CST, Thermo Fisher, R&D Systems, BD, Biolegend, Proteintech, ABclonal, Bio-Rad, Santa Cruz Biotechnology (SCBT), Novus Biologicals, Genetex, Abnova, Abcepta, Aviva Biosciences, MBL, BioXCell, Sino Biological, HuaBio

What are the Application segmentation covered in the Research Grade Antibodies Market report?

Ans: The Applications covered in the Research Grade Antibodies Market report are For Basic Research, For Drug Discovery, For Translational/Diagnostic Research, Others

What are the End User segmentation covered in the Research Grade Antibodies Market report?

Ans: The End users covered in the Research Grade Antibodies Market report are Pharmaceutical & Biotechnology Companies, CRO/CDMO Companies, Academic & Research Institutes, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Source
1.2.1 Global Research Grade Antibodies Market Size Growth Rate by Source: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Polyclonal Antibodies
1.3 Market by Host Species
1.3.1 Global Research Grade Antibodies Market Size Growth Rate by Host Species: 2020 VS 2024 VS 2031
1.3.2 Mouse Antibody
1.3.3 Rabbit Antibody
1.3.4 Goat Antibody
1.3.5 Sheep Antibody
1.3.6 Donkey Antibody
1.3.7 Chicken Antibody
1.3.8 Others
1.4 Market by Application
1.4.1 Global Research Grade Antibodies Market Size Growth Rate by Application: 2020 VS 2024 VS 2031
1.4.2 For Basic Research
1.4.3 For Drug Discovery
1.4.4 For Translational/Diagnostic Research
1.4.5 Others
1.5 Market by End User
1.5.1 Global Research Grade Antibodies Market Growth by End User: 2020 VS 2024 VS 2031
1.5.2 Pharmaceutical & Biotechnology Companies
1.5.3 CRO/CDMO Companies
1.5.4 Academic & Research Institutes
1.5.5 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Research Grade Antibodies Market Perspective (2020-2031)
2.2 Global Research Grade Antibodies Growth Trends by Region
2.2.1 Global Research Grade Antibodies Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Research Grade Antibodies Historic Market Size by Region (2020-2025)
2.2.3 Research Grade Antibodies Forecasted Market Size by Region (2026-2031)
2.3 Research Grade Antibodies Market Dynamics
2.3.1 Research Grade Antibodies Industry Trends
2.3.2 Research Grade Antibodies Market Drivers
2.3.3 Research Grade Antibodies Market Challenges
2.3.4 Research Grade Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Research Grade Antibodies Players by Revenue
3.1.1 Global Top Research Grade Antibodies Players by Revenue (2020-2025)
3.1.2 Global Research Grade Antibodies Revenue Market Share by Players (2020-2025)
3.2 Global Top Research Grade Antibodies Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Research Grade Antibodies Revenue
3.4 Global Research Grade Antibodies Market Concentration Ratio
3.4.1 Global Research Grade Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Research Grade Antibodies Revenue in 2024
3.5 Global Key Players of Research Grade Antibodies Head office and Area Served
3.6 Global Key Players of Research Grade Antibodies, Product and Application
3.7 Global Key Players of Research Grade Antibodies, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Research Grade Antibodies Breakdown Data by Source
4.1 Global Research Grade Antibodies Historic Market Size by Source (2020-2025)
4.2 Global Research Grade Antibodies Forecasted Market Size by Source (2026-2031)
5 Research Grade Antibodies Breakdown Data by End User
5.1 Global Research Grade Antibodies Historic Market Size by End User (2020-2025)
5.2 Global Research Grade Antibodies Forecasted Market Size by End User (2026-2031)
6 North America
6.1 North America Research Grade Antibodies Market Size (2020-2031)
6.2 North America Research Grade Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Research Grade Antibodies Market Size by Country (2020-2025)
6.4 North America Research Grade Antibodies Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Research Grade Antibodies Market Size (2020-2031)
7.2 Europe Research Grade Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Research Grade Antibodies Market Size by Country (2020-2025)
7.4 Europe Research Grade Antibodies Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Research Grade Antibodies Market Size (2020-2031)
8.2 Asia-Pacific Research Grade Antibodies Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Research Grade Antibodies Market Size by Region (2020-2025)
8.4 Asia-Pacific Research Grade Antibodies Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Research Grade Antibodies Market Size (2020-2031)
9.2 Latin America Research Grade Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Research Grade Antibodies Market Size by Country (2020-2025)
9.4 Latin America Research Grade Antibodies Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Research Grade Antibodies Market Size (2020-2031)
10.2 Middle East & Africa Research Grade Antibodies Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Research Grade Antibodies Market Size by Country (2020-2025)
10.4 Middle East & Africa Research Grade Antibodies Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam Research Grade Antibodies Introduction
11.1.4 Abcam Revenue in Research Grade Antibodies Business (2020-2025)
11.1.5 Abcam Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck Research Grade Antibodies Introduction
11.2.4 Merck Revenue in Research Grade Antibodies Business (2020-2025)
11.2.5 Merck Recent Development
11.3 CST
11.3.1 CST Company Details
11.3.2 CST Business Overview
11.3.3 CST Research Grade Antibodies Introduction
11.3.4 CST Revenue in Research Grade Antibodies Business (2020-2025)
11.3.5 CST Recent Development
11.4 Thermo Fisher
11.4.1 Thermo Fisher Company Details
11.4.2 Thermo Fisher Business Overview
11.4.3 Thermo Fisher Research Grade Antibodies Introduction
11.4.4 Thermo Fisher Revenue in Research Grade Antibodies Business (2020-2025)
11.4.5 Thermo Fisher Recent Development
11.5 R&D Systems
11.5.1 R&D Systems Company Details
11.5.2 R&D Systems Business Overview
11.5.3 R&D Systems Research Grade Antibodies Introduction
11.5.4 R&D Systems Revenue in Research Grade Antibodies Business (2020-2025)
11.5.5 R&D Systems Recent Development
11.6 BD
11.6.1 BD Company Details
11.6.2 BD Business Overview
11.6.3 BD Research Grade Antibodies Introduction
11.6.4 BD Revenue in Research Grade Antibodies Business (2020-2025)
11.6.5 BD Recent Development
11.7 Biolegend
11.7.1 Biolegend Company Details
11.7.2 Biolegend Business Overview
11.7.3 Biolegend Research Grade Antibodies Introduction
11.7.4 Biolegend Revenue in Research Grade Antibodies Business (2020-2025)
11.7.5 Biolegend Recent Development
11.8 Proteintech
11.8.1 Proteintech Company Details
11.8.2 Proteintech Business Overview
11.8.3 Proteintech Research Grade Antibodies Introduction
11.8.4 Proteintech Revenue in Research Grade Antibodies Business (2020-2025)
11.8.5 Proteintech Recent Development
11.9 ABclonal
11.9.1 ABclonal Company Details
11.9.2 ABclonal Business Overview
11.9.3 ABclonal Research Grade Antibodies Introduction
11.9.4 ABclonal Revenue in Research Grade Antibodies Business (2020-2025)
11.9.5 ABclonal Recent Development
11.10 Bio-Rad
11.10.1 Bio-Rad Company Details
11.10.2 Bio-Rad Business Overview
11.10.3 Bio-Rad Research Grade Antibodies Introduction
11.10.4 Bio-Rad Revenue in Research Grade Antibodies Business (2020-2025)
11.10.5 Bio-Rad Recent Development
11.11 Santa Cruz Biotechnology (SCBT)
11.11.1 Santa Cruz Biotechnology (SCBT) Company Details
11.11.2 Santa Cruz Biotechnology (SCBT) Business Overview
11.11.3 Santa Cruz Biotechnology (SCBT) Research Grade Antibodies Introduction
11.11.4 Santa Cruz Biotechnology (SCBT) Revenue in Research Grade Antibodies Business (2020-2025)
11.11.5 Santa Cruz Biotechnology (SCBT) Recent Development
11.12 Novus Biologicals
11.12.1 Novus Biologicals Company Details
11.12.2 Novus Biologicals Business Overview
11.12.3 Novus Biologicals Research Grade Antibodies Introduction
11.12.4 Novus Biologicals Revenue in Research Grade Antibodies Business (2020-2025)
11.12.5 Novus Biologicals Recent Development
11.13 Genetex
11.13.1 Genetex Company Details
11.13.2 Genetex Business Overview
11.13.3 Genetex Research Grade Antibodies Introduction
11.13.4 Genetex Revenue in Research Grade Antibodies Business (2020-2025)
11.13.5 Genetex Recent Development
11.14 Abnova
11.14.1 Abnova Company Details
11.14.2 Abnova Business Overview
11.14.3 Abnova Research Grade Antibodies Introduction
11.14.4 Abnova Revenue in Research Grade Antibodies Business (2020-2025)
11.14.5 Abnova Recent Development
11.15 Abcepta
11.15.1 Abcepta Company Details
11.15.2 Abcepta Business Overview
11.15.3 Abcepta Research Grade Antibodies Introduction
11.15.4 Abcepta Revenue in Research Grade Antibodies Business (2020-2025)
11.15.5 Abcepta Recent Development
11.16 Aviva Biosciences
11.16.1 Aviva Biosciences Company Details
11.16.2 Aviva Biosciences Business Overview
11.16.3 Aviva Biosciences Research Grade Antibodies Introduction
11.16.4 Aviva Biosciences Revenue in Research Grade Antibodies Business (2020-2025)
11.16.5 Aviva Biosciences Recent Development
11.17 MBL
11.17.1 MBL Company Details
11.17.2 MBL Business Overview
11.17.3 MBL Research Grade Antibodies Introduction
11.17.4 MBL Revenue in Research Grade Antibodies Business (2020-2025)
11.17.5 MBL Recent Development
11.18 BioXCell
11.18.1 BioXCell Company Details
11.18.2 BioXCell Business Overview
11.18.3 BioXCell Research Grade Antibodies Introduction
11.18.4 BioXCell Revenue in Research Grade Antibodies Business (2020-2025)
11.18.5 BioXCell Recent Development
11.19 Sino Biological
11.19.1 Sino Biological Company Details
11.19.2 Sino Biological Business Overview
11.19.3 Sino Biological Research Grade Antibodies Introduction
11.19.4 Sino Biological Revenue in Research Grade Antibodies Business (2020-2025)
11.19.5 Sino Biological Recent Development
11.20 HuaBio
11.20.1 HuaBio Company Details
11.20.2 HuaBio Business Overview
11.20.3 HuaBio Research Grade Antibodies Introduction
11.20.4 HuaBio Revenue in Research Grade Antibodies Business (2020-2025)
11.20.5 HuaBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Research Grade Antibodies Market Size Growth Rate by Source (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Monoclonal Antibodies
 Table 3. Key Players of Polyclonal Antibodies
 Table 4. Global Research Grade Antibodies Market Size Growth Rate by Host Species (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Key Players of Mouse Antibody
 Table 6. Key Players of Rabbit Antibody
 Table 7. Key Players of Goat Antibody
 Table 8. Key Players of Sheep Antibody
 Table 9. Key Players of Donkey Antibody
 Table 10. Key Players of Chicken Antibody
 Table 11. Key Players of Others
 Table 12. Global Research Grade Antibodies Market Size Growth Rate by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 13. Key Players of For Basic Research
 Table 14. Key Players of For Drug Discovery
 Table 15. Key Players of For Translational/Diagnostic Research
 Table 16. Key Players of Others
 Table 17. Global Research Grade Antibodies Market Size Growth by End User (US$ Million): 2020 VS 2024 VS 2031
 Table 18. Global Research Grade Antibodies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 19. Global Research Grade Antibodies Market Size by Region (2020-2025) & (US$ Million)
 Table 20. Global Research Grade Antibodies Market Share by Region (2020-2025)
 Table 21. Global Research Grade Antibodies Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 22. Global Research Grade Antibodies Market Share by Region (2026-2031)
 Table 23. Research Grade Antibodies Market Trends
 Table 24. Research Grade Antibodies Market Drivers
 Table 25. Research Grade Antibodies Market Challenges
 Table 26. Research Grade Antibodies Market Restraints
 Table 27. Global Research Grade Antibodies Revenue by Players (2020-2025) & (US$ Million)
 Table 28. Global Research Grade Antibodies Market Share by Players (2020-2025)
 Table 29. Global Top Research Grade Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Research Grade Antibodies as of 2024)
 Table 30. Ranking of Global Top Research Grade Antibodies Companies by Revenue (US$ Million) in 2024
 Table 31. Global 5 Largest Players Market Share by Research Grade Antibodies Revenue (CR5 and HHI) & (2020-2025)
 Table 32. Global Key Players of Research Grade Antibodies, Headquarters and Area Served
 Table 33. Global Key Players of Research Grade Antibodies, Product and Application
 Table 34. Global Key Players of Research Grade Antibodies, Date of Enter into This Industry
 Table 35. Mergers & Acquisitions, Expansion Plans
 Table 36. Global Research Grade Antibodies Market Size by Source (2020-2025) & (US$ Million)
 Table 37. Global Research Grade Antibodies Revenue Market Share by Source (2020-2025)
 Table 38. Global Research Grade Antibodies Forecasted Market Size by Source (2026-2031) & (US$ Million)
 Table 39. Global Research Grade Antibodies Revenue Market Share by Source (2026-2031)
 Table 40. Global Research Grade Antibodies Market Size by End User (2020-2025) & (US$ Million)
 Table 41. Global Research Grade Antibodies Revenue Market Share by End User (2020-2025)
 Table 42. Global Research Grade Antibodies Forecasted Market Size by End User (2026-2031) & (US$ Million)
 Table 43. Global Research Grade Antibodies Revenue Market Share by End User (2026-2031)
 Table 44. North America Research Grade Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. North America Research Grade Antibodies Market Size by Country (2020-2025) & (US$ Million)
 Table 46. North America Research Grade Antibodies Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Europe Research Grade Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Europe Research Grade Antibodies Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Europe Research Grade Antibodies Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Asia-Pacific Research Grade Antibodies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 51. Asia-Pacific Research Grade Antibodies Market Size by Region (2020-2025) & (US$ Million)
 Table 52. Asia-Pacific Research Grade Antibodies Market Size by Region (2026-2031) & (US$ Million)
 Table 53. Latin America Research Grade Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 54. Latin America Research Grade Antibodies Market Size by Country (2020-2025) & (US$ Million)
 Table 55. Latin America Research Grade Antibodies Market Size by Country (2026-2031) & (US$ Million)
 Table 56. Middle East & Africa Research Grade Antibodies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 57. Middle East & Africa Research Grade Antibodies Market Size by Country (2020-2025) & (US$ Million)
 Table 58. Middle East & Africa Research Grade Antibodies Market Size by Country (2026-2031) & (US$ Million)
 Table 59. Abcam Company Details
 Table 60. Abcam Business Overview
 Table 61. Abcam Research Grade Antibodies Product
 Table 62. Abcam Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 63. Abcam Recent Development
 Table 64. Merck Company Details
 Table 65. Merck Business Overview
 Table 66. Merck Research Grade Antibodies Product
 Table 67. Merck Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 68. Merck Recent Development
 Table 69. CST Company Details
 Table 70. CST Business Overview
 Table 71. CST Research Grade Antibodies Product
 Table 72. CST Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 73. CST Recent Development
 Table 74. Thermo Fisher Company Details
 Table 75. Thermo Fisher Business Overview
 Table 76. Thermo Fisher Research Grade Antibodies Product
 Table 77. Thermo Fisher Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 78. Thermo Fisher Recent Development
 Table 79. R&D Systems Company Details
 Table 80. R&D Systems Business Overview
 Table 81. R&D Systems Research Grade Antibodies Product
 Table 82. R&D Systems Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 83. R&D Systems Recent Development
 Table 84. BD Company Details
 Table 85. BD Business Overview
 Table 86. BD Research Grade Antibodies Product
 Table 87. BD Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 88. BD Recent Development
 Table 89. Biolegend Company Details
 Table 90. Biolegend Business Overview
 Table 91. Biolegend Research Grade Antibodies Product
 Table 92. Biolegend Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 93. Biolegend Recent Development
 Table 94. Proteintech Company Details
 Table 95. Proteintech Business Overview
 Table 96. Proteintech Research Grade Antibodies Product
 Table 97. Proteintech Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 98. Proteintech Recent Development
 Table 99. ABclonal Company Details
 Table 100. ABclonal Business Overview
 Table 101. ABclonal Research Grade Antibodies Product
 Table 102. ABclonal Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 103. ABclonal Recent Development
 Table 104. Bio-Rad Company Details
 Table 105. Bio-Rad Business Overview
 Table 106. Bio-Rad Research Grade Antibodies Product
 Table 107. Bio-Rad Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 108. Bio-Rad Recent Development
 Table 109. Santa Cruz Biotechnology (SCBT) Company Details
 Table 110. Santa Cruz Biotechnology (SCBT) Business Overview
 Table 111. Santa Cruz Biotechnology (SCBT) Research Grade Antibodies Product
 Table 112. Santa Cruz Biotechnology (SCBT) Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 113. Santa Cruz Biotechnology (SCBT) Recent Development
 Table 114. Novus Biologicals Company Details
 Table 115. Novus Biologicals Business Overview
 Table 116. Novus Biologicals Research Grade Antibodies Product
 Table 117. Novus Biologicals Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 118. Novus Biologicals Recent Development
 Table 119. Genetex Company Details
 Table 120. Genetex Business Overview
 Table 121. Genetex Research Grade Antibodies Product
 Table 122. Genetex Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 123. Genetex Recent Development
 Table 124. Abnova Company Details
 Table 125. Abnova Business Overview
 Table 126. Abnova Research Grade Antibodies Product
 Table 127. Abnova Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 128. Abnova Recent Development
 Table 129. Abcepta Company Details
 Table 130. Abcepta Business Overview
 Table 131. Abcepta Research Grade Antibodies Product
 Table 132. Abcepta Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 133. Abcepta Recent Development
 Table 134. Aviva Biosciences Company Details
 Table 135. Aviva Biosciences Business Overview
 Table 136. Aviva Biosciences Research Grade Antibodies Product
 Table 137. Aviva Biosciences Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 138. Aviva Biosciences Recent Development
 Table 139. MBL Company Details
 Table 140. MBL Business Overview
 Table 141. MBL Research Grade Antibodies Product
 Table 142. MBL Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 143. MBL Recent Development
 Table 144. BioXCell Company Details
 Table 145. BioXCell Business Overview
 Table 146. BioXCell Research Grade Antibodies Product
 Table 147. BioXCell Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 148. BioXCell Recent Development
 Table 149. Sino Biological Company Details
 Table 150. Sino Biological Business Overview
 Table 151. Sino Biological Research Grade Antibodies Product
 Table 152. Sino Biological Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 153. Sino Biological Recent Development
 Table 154. HuaBio Company Details
 Table 155. HuaBio Business Overview
 Table 156. HuaBio Research Grade Antibodies Product
 Table 157. HuaBio Revenue in Research Grade Antibodies Business (2020-2025) & (US$ Million)
 Table 158. HuaBio Recent Development
 Table 159. Research Programs/Design for This Report
 Table 160. Key Data Information from Secondary Sources
 Table 161. Key Data Information from Primary Sources
 Table 162. Authors List of This Report


List of Figures
 Figure 1. Research Grade Antibodies Picture
 Figure 2. Global Research Grade Antibodies Market Size Comparison by Source (2020-2031) & (US$ Million)
 Figure 3. Global Research Grade Antibodies Market Share by Source: 2024 VS 2031
 Figure 4. Monoclonal Antibodies Features
 Figure 5. Polyclonal Antibodies Features
 Figure 6. Global Research Grade Antibodies Market Size Comparison by Host Species (2020-2031) & (US$ Million)
 Figure 7. Mouse Antibody Features
 Figure 8. Rabbit Antibody Features
 Figure 9. Goat Antibody Features
 Figure 10. Sheep Antibody Features
 Figure 11. Donkey Antibody Features
 Figure 12. Chicken Antibody Features
 Figure 13. Others Features
 Figure 14. Global Research Grade Antibodies Market Size Comparison by Application (2020-2031) & (US$ Million)
 Figure 15. For Basic Research Features
 Figure 16. For Drug Discovery Features
 Figure 17. For Translational/Diagnostic Research Features
 Figure 18. Others Features
 Figure 19. Global Research Grade Antibodies Market Size by End User (2020-2031) & (US$ Million)
 Figure 20. Global Research Grade Antibodies Market Share by End User: 2024 VS 2031
 Figure 21. Pharmaceutical & Biotechnology Companies Case Studies
 Figure 22. CRO/CDMO Companies Case Studies
 Figure 23. Academic & Research Institutes Case Studies
 Figure 24. Others Case Studies
 Figure 25. Research Grade Antibodies Report Years Considered
 Figure 26. Global Research Grade Antibodies Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 27. Global Research Grade Antibodies Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 28. Global Research Grade Antibodies Market Share by Region: 2024 VS 2031
 Figure 29. Global Research Grade Antibodies Market Share by Players in 2024
 Figure 30. Global Research Grade Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 31. The Top 10 and 5 Players Market Share by Research Grade Antibodies Revenue in 2024
 Figure 32. North America Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. North America Research Grade Antibodies Market Share by Country (2020-2031)
 Figure 34. United States Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Canada Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Europe Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Europe Research Grade Antibodies Market Share by Country (2020-2031)
 Figure 38. Germany Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. France Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. U.K. Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Italy Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Russia Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Ireland Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Asia-Pacific Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Asia-Pacific Research Grade Antibodies Market Share by Region (2020-2031)
 Figure 46. China Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Japan Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. South Korea Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Southeast Asia Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. India Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Australia & New Zealand Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Latin America Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Latin America Research Grade Antibodies Market Share by Country (2020-2031)
 Figure 54. Mexico Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 55. Brazil Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 56. Middle East & Africa Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 57. Middle East & Africa Research Grade Antibodies Market Share by Country (2020-2031)
 Figure 58. Israel Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 59. Saudi Arabia Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 60. UAE Research Grade Antibodies Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 61. Abcam Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 62. Merck Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 63. CST Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 64. Thermo Fisher Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 65. R&D Systems Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 66. BD Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 67. Biolegend Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 68. Proteintech Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 69. ABclonal Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 70. Bio-Rad Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 71. Santa Cruz Biotechnology (SCBT) Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 72. Novus Biologicals Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 73. Genetex Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 74. Abnova Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 75. Abcepta Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 76. Aviva Biosciences Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 77. MBL Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 78. BioXCell Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 79. Sino Biological Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 80. HuaBio Revenue Growth Rate in Research Grade Antibodies Business (2020-2025)
 Figure 81. Bottom-up and Top-down Approaches for This Report
 Figure 82. Data Triangulation
 Figure 83. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc